about
A conserved sorting-associated protein is mutant in chorea-acanthocytosisGenetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosisAn 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisA polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisA genome-wide association study in progressive multiple sclerosisGenome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data.On the utility of data from the International HapMap Project for Australian association studies.Variants of ST8SIA1 are associated with risk of developing multiple sclerosis.Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonismEffects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction levelFine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis.Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.Exome array analysis suggests an increased variant burden in families with schizophrenia.Current status of the Plasmodium falciparum genome project.Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe.The ATP-binding cassette (ABC) gene family of Plasmodium falciparum.Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics.Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis.HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.Common variation in the MOG gene influences transcript splicing in humans.A DNA resequencing array for genes involved in Parkinson's disease.A genomewide association study of smoking relapse in four European population-based samplesSaliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray StudiesHeterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognitionGene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosisValidation of linear cerebral atrophy markers in multiple sclerosisA YAC contig map of Plasmodium falciparum chromosome 4: characterization of a DNA amplification between two recently separated isolatesThe chromosomal organization of the Plasmodium falciparum var gene family is conservedThe chorea of McLeod syndromeCD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisGenetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan
P50
Q24291269-BC446D8A-E145-4236-A437-6D6AE00CF1A2Q24563911-2DF222A5-B00C-44EB-9CEC-1BDB3DCE24A9Q24599479-F868E14E-F2E7-45D5-9944-F35E2CC7C23EQ24635370-18BEBA41-15A3-41E3-8C4E-7066BC82065CQ28748710-E9587ACC-8120-48BE-A5B2-73785806C9FDQ28943404-530F5D55-97AE-4CF9-8002-4DE37928C77AQ29417047-0CB9BEA4-AEF3-4677-A6C4-FB646E85F65CQ30980357-42AAEF77-4573-45BF-9284-ED967DED0530Q31026850-FB5FE6A0-C90D-49EF-8F43-1EFFF3644CF7Q31029393-F40666A5-2F40-4820-91AA-EDBC88D03A59Q33350182-79B2A2CB-7C57-4A4A-BAB7-99BE581EE223Q33924503-A0948074-9360-4499-AFC4-EE86D86499D8Q34151623-A5E88610-DD73-4EE9-8041-E6FC23E8CFB5Q34947204-26F08595-88AE-4530-970D-9E5D3849D1B2Q34976409-718D528D-8F5F-4572-A138-37F14B110424Q36246917-C08B9721-2B1F-4500-B63C-20024225A2F2Q36591835-EFA9D5F1-5CDD-4471-818F-ED68F6F98463Q38320074-B7B4480D-172E-4976-807C-9042F836EBF1Q40431065-699EA570-E41D-4A8E-81B5-67213EFCD779Q41141627-D022ABE0-E70D-4D0C-AB83-872C72FB8B75Q41849532-EB1D49B8-3ED8-48DB-AD20-3B2C680854B0Q41931004-85D9C7C3-2F07-481C-8A38-6395D17D1AC6Q42249749-722EB5EF-5170-4622-991A-C00F351C6655Q46956244-F46368D0-71EF-48FE-8A26-5389B8FA2AA7Q47947454-8F9C2233-06B5-47A5-ABA1-EC22F7C440F3Q50276912-B4A4EB7B-88A4-4541-A411-50A70DC10F05Q51666180-FFF6E479-6BB7-43E1-95AD-1CCFF47F6F28Q54536407-090620A9-FC25-4DFE-A93C-5390A80CE5F1Q57104749-13AD1A08-FD51-4877-8443-10D4C92755A1Q57667565-212C016E-3D4A-4E71-940C-557BD212B747Q58863566-5788453E-DE26-4084-9230-B6BE5E782A6EQ58863582-F7FD7392-1C5F-46BB-B1F2-7442E59644CEQ59655810-0DC4FC02-518E-48C7-BAB2-5EF5424B99BFQ71846498-EF7A29CE-59F7-4A53-A13A-1EB4317AE4E4Q73535912-C4969B58-DC77-4F63-93BF-3AD6C640B186Q77360479-4452C8CE-F4E4-4361-B1F8-0678AC07B46CQ81066219-51A9F645-78E1-45C4-9F3E-03F36BE6FA9DQ84572528-6C78CD22-3E64-4D70-9B37-952B1CA9D359
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Justin P Rubio
@ast
Justin P Rubio
@en
Justin P Rubio
@es
Justin P Rubio
@nl
type
label
Justin P Rubio
@ast
Justin P Rubio
@en
Justin P Rubio
@es
Justin P Rubio
@nl
prefLabel
Justin P Rubio
@ast
Justin P Rubio
@en
Justin P Rubio
@es
Justin P Rubio
@nl
P106
P1153
7202580500
P31
P496
0000-0003-3750-917X